electronic records – Page 16

How to Prevent Raw Data Archival Strategy in CDS (Chromatography Data System) Risks

Strategies to Mitigate CDS Data Integrity Risks in Pharmaceutical Manufacturing In pharmaceutical manufacturing, ensuring the integrity of data generated by Chromatography Data Systems (CDS) is critical for compliance and quality…

Data Integrity Inspection Readiness for OOS and OOT Investigations

Ensuring Data Integrity for OOS and OOT Investigations During Regulatory Inspections In the highly regulated pharmaceutical industry, maintaining data integrity is paramount, especially during Out of Specification (OOS) and Out…

Step-by-Step Guide to Managing Manual Baseline Corrections Under ALCOA+ Expectations

Managing Manual Baseline Corrections in Compliance with ALCOA+ Standards In the realm of pharmaceutical manufacturing and quality assurance, integrity of data generated through chromatography is paramount. Errors related to manual…

How to Demonstrate Periodic Review of GxP Computerized Systems

Ensuring Compliance Through Periodic Review of GxP Computerized Systems In a hypothetical scenario across a pharmaceutical manufacturing facility, the quality assurance team notices discrepancies in electronic batch records during routine…

Why Integration Parameter Locking Happens and How QA Teams Should Control It

Understanding and Controlling Integration Parameter Locking in CDS The pharmaceutical industry increasingly relies on automated data acquisition and analysis, particularly through chromatography data systems (CDS). However, issues like integration parameter…

Data Integrity During Inspections: Questions on Review by Exception

Ensuring Data Integrity during Inspections: Navigating Review by Exception Pharmaceutical manufacturers often encounter challenges related to data integrity during regulatory inspections. The integrity of data not only affects compliance status…

Inspection-Ready Approach to CDS Access Recertification in Pharmaceutical Operations

Strategies to Mitigate CDS Access Recertification Issues in Pharmaceutical Operations In the intricate landscape of pharmaceutical operations, maintaining data integrity in Chromatography Data Systems (CDS) is critical. Frequent access recertification…

Inspection-Ready Approach to CDS Access Recertification in Pharmaceutical Operations

Effective Strategies for Addressing CDS Data Integrity Risks in Pharmaceutical Operations In the ever-evolving landscape of pharmaceutical manufacturing, ensuring the integrity of data generated from Chromatography Data Systems (CDS) is…

How to Build a Data Integrity War Room Evidence Index

Establishing a Robust Data Integrity Evidence Index for Inspections In today’s pharmaceutical manufacturing landscape, data integrity is of paramount importance. Regulatory bodies such as the FDA and EMA have increased…

Legacy CDS Compliance: Root Causes, GMP Risks, and CAPA Controls

Addressing Legacy CDS Compliance: Identifying Root Causes and Implementing Effective CAPA Controls In pharmaceutical development and manufacturing, compliance with data integrity standards is paramount for ensuring the quality and safety…

Regulatory Inspection Expectations for Data Integrity Governance

Understanding Data Integrity Governance for Successful Regulatory Inspections In today’s highly regulated pharmaceutical environment, the integrity of data is paramount, particularly during inspections. Failure to maintain data integrity can lead…

How to Prevent Analyst Privilege Creep in CDS (Chromatography Data System) Risks

Addressing Analyst Privilege Creep in Chromatography Data Systems Analysts in pharmaceutical manufacturing often face challenges related to Chromatography Data Systems (CDS) and data integrity. A rising concern in this area…